Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Clin Psychopharmacol. 2016 Jun;36(3):222–228. doi: 10.1097/JCP.0000000000000501

Figure 1.

Figure 1

Flow Chart

Flowchart of the eligible sample of 4870 adult individuals with SUD diagnosis prescribed MPH treatment between January 1, 2006, and December 31, 2009 identified from the register linkages. Individuals with inadequate follow-up time (n= 590), treatment discontinuation before day 100 (n=1134), and lack of dose information (n=487) was excluded. The main analyses included 2659 individuals with a known prescribed MPH dose at day 100.